Regulus Therapeutics RGLS
$ 1.47
5.0%
Quarterly report 2024-Q3
added 11-07-2024
Regulus Therapeutics EV/EBITDA Ratio 2011-2024 | RGLS
Annual EV/EBITDA Ratio Regulus Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
1.71 | -1.62 | 0.0534 | -0.243 | -1.5 | -0.928 | -5.29 | -19.7 | -21.2 | -1.62 | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
1.71 | -21.2 | -5.03 |